22nd Century Group Reports First Quarter 2020 Financial Results

WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII) (22nd Century or the Company), a leading plant biotechnology company focused on reduced nicotine tobacco and hemp/cannabis plant genetics research and development, today repo…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *